ObjectiveTo explore the clinical effect of goniosynechialysis combined with cataract phacoemulsification for the treatment of primary angle-closure glaucoma (PACG) and concomitant cataract. MethodsA total of 64 patients with PACG and concomitant cataract were randomly divided into control group or observation group, with 32 cases in each group. The control group received trabeculectomy combined with cataract phacoemulsification for treatment, while the observation group received goniosynechialysis combined with cataract phacoemulsification for treatment. The logarithm of minimum resolution angle (logMAR) visual acuity, intraocular pressure, central anterior chamber depth, chamber angle status, corneal endothelial cell density, central corneal thickness, and average area of corneal endothelial cells before operation and 3 months after operation, as well as occurrence of complications 3 months after operation were compared between patients of the two groups. ResultsAfter 3 months of operation, patients of both groups obtained decreased logMAR visual acuity, intraocular pressure, corneal endothelial cell density, central corneal thickness, and average area of corneal endothelial cells, whereas elevated central anterior chamber depth as compared with before operation (P<0.05); furthermore, the observation group exhibited higher logMAR visual acuity, intraocular pressure, central anterior chamber depth, and corneal endothelial cell density as compared with the control group, and superior chamber angle status, as well as a thin central corneal thickness, a smaller average area of corneal endothelial cells, and a lower total incidence rate of complications as compared with the control group (P<0.05). ConclusionEmploying goniosynechialysis combined with cataract phacoemulsification for the treatment of patients with PACG and concomitant cataract is beneficial for decreasing intraocular pressure, improving visual acuity, ameliorating chamber angle status in patients, exerting a smaller damage on corneal endothelium, and a lower incidence rate of complications.